Regulation of the instantaneous inward rectifier and the delayed outward rectifier potassium channels by captopril and angiotensin II via the phosphoinositide-3 kinase pathway in volume-overload-induced hypertrophied cardiac myocytes

Medical Science Monitor

Volumn 17, Issue 7, 2011, Pages

  Alvin, Zikiar ^a   Laurence, Graham G ^a   Coleman, Bernell R ^a   Zhao, Aiqiu ^a   Hajj Moussa, Majd ^b   Haddad, Georges E ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Universite St Esprit de Kaslik   (United States)

Author keywords

Angiotensin converting enzyme inhibitor; Cardiac hypertrophy; K channels; PI3K Akt

Indexed keywords

ANGIOTENSIN II; CAPTOPRIL; DELAYED OUTWARD RECTIFIER POTASSIUM CHANNEL; DIPEPTIDYL CARBOXYPEPTIDASE; INWARD RECTIFIER POTASSIUM CHANNEL; PHOSPHATIDYLINOSITOL 3 KINASE; POTASSIUM CHANNEL; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEART HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CELL; INTRACELLULAR SIGNALING; MALE; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; RAT; VOLTAGE CLAMP; WESTERN BLOTTING;

EID: 79959960188     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.881843     Document Type: Article

References (32)

1. Cantor EJ, Babick AP, Vasanji Z et al: A comparative serial echocardio-graphic analysis of cardiac structure and function in rats subjected to pressure or volume overload. J Mol Cell Cardiol, 2005; 38(5): 777-86
2. Kobayashi M, Machida N, Tanaka R et al: Effects of beta-blocker on left ventricular remodeling in rats with volume overload cardiac failure. J Vet Med Sci, 2008; 70(11): 1231-37
3. Matsubara LS, Narikawa S, Ferreira AL et al: [Myocardial remodeling in chronic pressure or volume overload in the rat heart]. Arq Bras Cardiol, 2006; 86(2): 126-30
4. Frey N, Olson EN: Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol, 2003; 65: 45-79
5. Yano N, Suzuki D, Endoh M et al: A novel phosphoinositide 3-kinase-dependent pathway for angiotensin II/AT-1 receptor-mediated induction of collagen synthesis in MES-13 mesangial cells. J Biol Chem, 2007; 282(26): 18819-30
6. Liu HW, Cheng B, Yu WL et al: Angiotensin II regulates phosphoinosit-ide 3 kinase/Akt cascade via a negative crosstalk between AT1 and AT2 receptors in skin fbroblasts of human hypertrophic scars. Life Sci, 2006; 79(5): 475-83
7. Bartnicki P, Majewska E, Wilk R et al: Captopril and losartan modify mitogen-induced proliferative response and expression of some differentiation antigents on peripheral blood mononuclear cells in chronic uraemic patients. Arch Med Sci, 2009; 5(3): 401-7
8. Rose J, Armoundas AA, Tian Y et al: Molecular correlates of altered expression of potassium currents in failing rabbit myocardium. Am J Physiol Heart Circ Physiol, 2005; 288(5): H2077-87
9. Stengl M, Ramakers C, Donker DW et al: Temporal patterns of electrical remodeling in canine ventricular hypertrophy: focus on IKs down regulation and blunted beta-adrenergic activation. Cardiovasc Res, 2006; 72(1): 90-100
10. Tsuji Y, Opthof T, Kamiya K et al: Pacing-induced heart failure causes a reduction of delayed rectifier potassium currents along with decreases in calcium and transient outward currents in rabbit ventricle. Cardiovasc Res, 2000; 48(2): 300-9
11. Wang YH, Shi CX, Dong F et al: Inhibition of the rapid component of the delayed rectifer potassium current in ventricular myocytes by an-giotensin II via the AT1 receptor. Br J Pharmacol, 2008; 154(2): 429-39
12. Zankov DP, Omatsu-Kanbe M, Isono T et al: Angiotensin II potentiates the slow component of delayed rectifer K+ current via the AT1 receptor in guinea pig atrial myocytes. Circulation, 2006; 113(10): 1278-86
13. Beuckelmann DJ, Nabauer M, Erdmann E: Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res, 1993; 73(2): 379-85
14. Domenighetti AA, Boixel C, Cefai D et al. Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current down regulation. J Mol Cell Cardiol, 2007; 42(1): 63-70
15. Tatli E, Aktoz M, Altun M: Do plasma leptin levels predict diastolic dysfunction in patients with hypertension? Arch Med Sci, 2009; 5(3): 342-46
16. Furukawa T, Myerburg RJ, Furukawa N et al: Metabolic inhibition of ICa,L and IK differs in feline left ventricular hypertrophy. Am J Physiol, 1994; 266(3 Pt 2): H1121-31
17. Teos LY, Zhao A, Alvin Z et al: Basal and IGF-I-dependent regulation of potassium channels by MAP kinases and PI3-kinase during eccentric cardiac hypertrophy. Am J Physiol Heart Circ Physiol, 2008; 295(5): H1834-45
18. Cerbai E, Barbieri M, Li Q et al: Ionic basis of action potential prolongation of hypertrophied cardiac myocytes isolated from hypertensive rats of different ages. Cardiovasc Res, 1994; 28(8): 1180-87
19. Momtaz A, Coulombe A, Richer P et al: Action potential and plateau ionic currents in moderately and severely DOCA-salt hypertrophied rat hearts. J Mol Cell Cardiol, 1996; 28(12): 2511-22
20. Thuringer D, Deroubaix E, Coulombe A et al: Ionic basis of the action potential prolongation in ventricular myocytes from Syrian hamsters with dilated cardiomyopathy. Cardiovasc Res, 1996; 31(5): 747-57
21. Aiello EA, Cingolani HE: Angiotensin II stimulates cardiac L-type Ca(2+) current by a Ca(2+)- and protein kinase C-dependent mechanism. Am J Physiol Heart Circ Physiol, 2001;280(4): H1528-36
22. Haddad GE, Coleman BR, Zhao A et al: Modulation of atrial contraction by PKA and PKC during the compensated phase of eccentric cardiac hypertrophy. Basic Res Cardiol, 2004; 99(5): 317-27
23. Haddad GE, Coleman BR, Zhao A et al: Regulation of atrial contraction by PKA and PKC during development and regression of eccentric cardiac hypertrophy. Am J Physiol Heart Circ Physiol, 2005; 288(2): H695-704
24. Gassanov N, Brandt MC, Michels G et al: Angiotensin II-induced changes of calcium sparks and ionic currents in human atrial myocytes: potential role for early remodeling in atrial fibrillation. Cell Calcium, 2006; 39(2): 175-86
25. Rials SJ, Xu X, Wu Y et al: Regression of LV hypertrophy with captopril normalizes membrane currents in rabbits. Am J Physiol, 1998; 275(4 Pt 2): H1216-H1224
26. Diniz GP, Carneiro-Ramos MS, Barreto-Chaves ML: Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway. Basic Res Cardiol, 2009; 104(6): 653-67
27. Hingtgen SD, Tian X, Yang J et al: Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyo-cyte hypertrophy. Physiol Genomics, 2006; 26(3): 180-91
28. Rabkin SW, Goutsouliak V, Kong JY: Angiotensin II induces activation of phosphatidylinositol 3-kinase in cardiomyocytes. J Hypertens, 1997; 15(8): 891-99
29. Rebas E, Lachowicz L, Mussur M et al: The activity of protein tyrosine kinases of rat heart after ischemia and reperfusion. Med Sci Monit, 2001; 7(5): 884-88
30. Zhao A, Alvin Z, Laurence G et al: Cross-talk between MAPKs and PI-3K pathways alters the functional density of I(K) channels in hypertrophied hearts. Ethn Dis, 2010; 20(1 Suppl.1): S1-24
31. Korantzopoulos P, Kolettis T, Siogas K et al: Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit, 2003; 9(9): RA225-RA229
32. Misra MK, Sarwat M, Bhakuni P et al: Oxidative stress and ischemic myocardial syndromes. Med Sci Monit, 2009; 15(10): RA209-RA219